191,129 karma · joined May 31, 2011
“Versus” implies intent. Apollo owning McGraw Hill doesn’t explain falling scores across the entire OECD.
What currently constitutes these studies seems to be a mix of propaganda and bullshit. But that sort of underlines the point that we have an impoverished set of common facts.
Teachers collectively became useless a decade ago? As a cohort? They were fine until then, but then suddenly collectively and globally decided to start sucking?
Very few are also asking for less bureaucracy, which in this case could potentially increase state capacity to pursue civic goals.
It does raise the question of the value of California’s bureaucratic burden.
It looks like credible evidence has been raised. But I see zero evidence any international organizations are investigating in the way that term is usually used. “Have taken note of” is more accurate.
TL; DR There are allegations this source brought up which don't seem to have any official corroboration. TV4SE met with election observers, but I see no evidence any credible observers have said they will "invetigate" as no observers were sent to the election. The most ODIHR have said is that they would consider this when deciding whether to send observers in the future.
These aren't a universal cost. When rates change, some landlords' costs go up. But some don't. That lets the latter set the marginal price.
If everyone's costs go up the same amount, it's collusion without communication. In an inelastic market like San Francisco's, you'd expect prices to rise.
To be fair, mobile phones being locked down probably contributed to the mass adoption of e.g. mobile payments and banking.
[1] https://www.ft.com/content/82dbd39c-f8dd-4ef1-8a80-d430a2257...
This is an incentive to build. Not to manage downside risk.
Healthcare is the same. It just turns out subsidizing it from wages works because healthy people are more productive.
Profitability isn’t a hard limit. But if something isn’t internally profitable, it requires an external partner to get going.
He isn’t wrong. But selling potential cures for cancer won’t cut it.